All News about Travere Therapeutics Inc
Via GlobeNewswire
Via Benzinga
Where Travere Therapeutics Stands With Analysts
December 15, 2023
Via Benzinga
Travere Therapeutics Provides Corporate Update and 2024 Outlook
January 08, 2024
Via GlobeNewswire
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Where Travere Therapeutics Stands With Analysts
November 20, 2023
Via Benzinga
Preview: Travere Therapeutics's Earnings
November 06, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
Travere Therapeutics Reports Third Quarter 2023 Financial Results
November 07, 2023
Via GlobeNewswire
Travere Therapeutics to Report Third Quarter 2023 Financial Results
October 24, 2023
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free